The White House’s pandemic readiness team is quietly reducing its part-time workforce.
Recently, Dr. Gerald Parker, who was overseeing the White House Pandemic Preparedness Office, stepped down as Senior Director of the National Security Council’s Bioscience and Pandemic Response Division. His resignation might not have come as a surprise, particularly since, well, the BioSecurity Office currently operates without any full-time staff. Reports indicate that Parker has been in a sort of limbo since late June.
This situation highlights gaps in pandemic preparedness and public health initiatives, which have been on the decline. With outbreaks of measles and the spread of H5N1 bird flu across U.S. farms, the White House office responsible for managing biological threats is practically nonexistent.
Established in 2022, the Office of Pandemic Preparedness and Response (OPPR) enjoyed bipartisan backing aimed at improving pandemic readiness. It worked in conjunction with the National Security Council’s Global Health Security and Biodefense Bureau, which was renamed Bioscience and Pandemic Response in 2025.
Major General Paul Friedrich, the first director of OPPR, informed Congress that the office would build on efforts made by various administrations over the past two decades, acknowledging the growing frequency and severity of biological threats.
During its brief existence, OPPR aided in coordinating federal responses to biological threats and established international partnerships to safeguard the pharmaceutical supply chain, among other initiatives.
When Parker was appointed to lead the Bureau, many had hoped that his decades of experience would contribute to a seamless integration of OPPR into the National Security Council. However, his approach seemed to lack a necessary sense of urgency.
Before the administration transition, OPPR had a staff of around 20, complemented by about 10 at the NSC. As is typical with political appointments, many staff resigned to make way for new appointments. The follow-up administration didn’t fill these roles, leaving only about five staff members in each office. Without new leadership and support, existing OPPR staff began resigning one by one, and by late June, the office was left mostly empty, with just Parker and part-time staff remaining.
History seems to repeat itself. In 2018, the Trump administration dissolved the NSC’s Global Health Security and Biodefense Bureau, and in 2024, there were plans to disband OPPR as well. The diminishing capabilities in biosecurity reflect an ongoing pattern, but reducing full-time pandemic preparedness roles to zero is, frankly, reckless.
The difference between controlling a health crisis and facing a catastrophe often hinges on early detection and swift, coordinated responses. Yet, maintaining the necessary speed and unity is continually thwarted as the U.S. dismantles its preparatory efforts during calmer periods, only to struggle to rebuild when crises arise.
OPPR was established to break this cycle, aiming to serve as a permanent hub for pandemic preparation and government coordination.
While its creation was a significant step forward, there have been shortcomings. Without dedicated funding from Congress, OPPR finds itself vulnerable to shifting priorities. Although it functioned well with BPR, effective collaboration shouldn’t be reliant on individual leadership alone.
Coordination for both domestic and global preparedness should become an inherent part of the system to guarantee continuity, regardless of personnel changes. Lacking that foundational structure, even a functional partnership can unravel when key individuals leave.
The current leadership void presents risks, but it can also serve as a chance to rebuild more intelligently. The White House could utilize this moment to centralize preparedness efforts under a cohesive leadership framework, ensuring consistent funding and full-time experts able to coordinate during emergencies.
Flawed policies are only part of the problem when leadership lacks unification and adequate resources. It’s a risky gamble not just for lives, but also for the economy and national security. We can’t afford to wait for the next pandemic to catch us off guard.
